The economic burden of Parkinson disease among Medicare beneficiaries

BACKGROUND: The progressive nature of Parkinson disease (PD), together with a lack of curative treatments, contributes to its economic burden. OBJECTIVE: To estimate the longitudinal incremental costs attributable to PD among Medicare beneficiaries. METHODS: In this retrospective cohort study, we us...

Descripción completa

Detalles Bibliográficos
Autores principales: Albarmawi, Husam, Zhou, Shujia, Shulman, Lisa M, Gandhi, Aakash Bipin, Johnson, Abree, Myers, Daniela E, Gray, David, Alvir, Jose, Onukwugha, Eberechukwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372956/
https://www.ncbi.nlm.nih.gov/pubmed/35332791
http://dx.doi.org/10.18553/jmcp.2022.28.4.405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372956/
https://www.ncbi.nlm.nih.gov/pubmed/35332791
http://dx.doi.org/10.18553/jmcp.2022.28.4.405

Ejemplares similares